Yuzhe Shi

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

10h-index696citations42works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(28), Biomedical Ethics and Regulation(15), Acute Lymphoblastic Leukemia research(7), Cancer Immunotherapy and Biomarkers(4), Acute Myeloid Leukemia Research(4)

Publications42 total

A single phospho-LCK flow-cytometry readout predicts dasatinib sensitivity in paediatric T-cell acute lymphoblastic leukaemia
2025Open Access
HIV immune evasin Nef enhances allogeneic CAR T cell potency
Nature·2025· 13 cited
Construction of a magnetic driven-quantum dots ratiometric fluorescence-immunosensor for rapid and accurate detection of C-reactive protein
Nano Research·2024· 1 citedOpen Access
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies
Nature Cancer·2024· 16 citedOpen Access
Fusion transcripts are present in early progenitor cells in KMT2A-rearranged B-ALL
Leukemia·2024· 3 citedOpen Access
Figure S2 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S6 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S5 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Table S1 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S3 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S3 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S1 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S6 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Data from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S8 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S4 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S9 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S8 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Table S1 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
Figure S5 from Disruption of <i>SUV39H1</i>-Mediated H3K9 Methylation Sustains CAR T-cell Function
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Michel Sadelain(26), Anton Dobrin(25), Nayan Jain(23), Zeguo Zhao(23), Richard P. Koche(23), Chenling Xu(23), Yosi Gozlan(23), Antonino Montalbano(23), David Brocks(23), Michael Lopez(23), Gertrude Gunset(23), Theodoros Giavridis(23), Olaf Heidenreich(7), Ricky Tirtakusuma(6), Sirintra Nakjang(5), Helen J. Blair(5), Paul Milne(4), Josef Vormoor(4), Simon Bomken(4), Shu‐Yong Lin(3)